胡汉华, 盛磊, 哈木拉提·吾甫尔, 等. 维药异常黑胆质成熟剂的抗肿 瘤作用及其对细胞迁移的影响[J]. 科技导报, 2011, 29(3): 62-65. Hu Hanhua, Sheng Lei, Upur Halmurat, et al. Anti-cancer effects of Uighur medicine abnormal Savda Munzip and its influence on cell migration [J]. Science & Technology Review, 2011, 29(3): 62-65.
[2]
张拴成, 肖红玲, 王丽娜, 等. 消瘀通络散对乳腺增生模型大鼠血清激 素水平的影响[J]. 中国中医基础医学杂志, 2012, 18(1): 58-60. Zhang Shuancheng, Xiao Hongling, Wang Lina, et al. Effects of Xiaoyu Tongluo San on breast morphology and endocrine in rats with hyperplasia of mammary glands[J]. Chinese Journal of Basic Medicine in Traditional Chinese Medicine, 2012, 18(1): 58-60.
[3]
马民, 李德辉, 张桂娟, 等. 乳癖霜外用对乳腺增生模型大鼠乳腺组织 病理形态学和AP-2et、C-erbB-2 表达的影响[J]. 中国老年学杂志, 2012, 32(4): 728-742. Ma Min, Li Dehui, Zhang Guijuan, et al. Effect of Rupi cream on histomorphology and AP-2et and C-erbB-2 expressions in rats with hyperplasia of mammary gland[J]. Chinese Journal of Gerontology, 2012, 32(4): 728-742.
[4]
中国医学百科全书编辑委员会. 中国医学百科全书：维吾尔医学[M]. 上海: 上海科学技术出版社, 2005: 26-30. Chinese Pharmacopoeia Commission. Traditional Uighur medicine of China medical encyclopaedia[M]. Shanghai: Shanghai Scientific and Technical Publishers, 2005: 26-30.
[5]
哈木拉提·吾甫尔. 维吾尔医学气质体液论及其现代研究[M]. 乌鲁木 齐: 新疆科学技术出版社, 2003: 44-52. Upur Halmurat. Theory of Mizaj and Hilit in Uighur medicine and modern study[M]. Urumqi: Xinjiang Scientific and Technical Publisher, 2003: 44-52.
[6]
阿衣努尔·买提斯迪克, 哈木拉提·吾甫尔, 玉山江, 等. 305例2型糖 尿病维医异常体液分型的量化诊断入选项专家咨询研究[J]. 科技导 报, 2012, 30(2): 39-45. Maitisidike Ayinuer, Upur Halmurat, Yu Shanjiang, et al. Screening of quantitative diagnosis indices of typing abnormal hilit syndrome in Uighur medicine using delphi method with 305 cases of type 2 diabetes[J]. Science & Technology Review, 2012, 30(2): 39-45.
[7]
哈木拉提·吾甫尔, 阿衣努尔·买提斯迪克, 吾尔古丽·阿卜都来海提, 等. 180例哮喘病维医异常体液分型的量化诊断入选项专家咨询研究[J]. 科技导报, 2011, 29(32): 36-42. Upur Halmurat, Maitisidike Ayinuer, Abudulaihait Wuerguli, et al. Screening of quantitative diagnosis indices of typing abnormal hilit syndrome in uighur medicine using delphi method, a survey of 180 cases of bronchial asthma [J]. Science & Technology Review, 2011, 29 (32): 36-42.
[8]
哈木拉提·吾甫尔. 能够使异常黑胆质型体液成熟和清除的药物及其 制备方法: 中国, 02130082.8[P]. 2003-04-16. Upur Halmurat. Preparation method of abnormal Savda Munziq and mishill on the effect of abnormal savda syndrome: China, 02130082.8[P]. 2003-04-16.
[9]
罗伦才, 季小平, 黄兰雅, 等. 均匀设计法用于乳腺增生动物模型复制 的研究[J]. 中国实验方剂学杂志, 2011, 17(7): 204-206. Luo Luncai, Ji Xiaoping, Huang Lanya, et al. Animal model replication of proliferative breast by homogeneous design[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2011, 17(7): 204-206.
[10]
高攀, 张秀军, 于玉领, 等. 蚌埠市农村已婚妇女乳腺疾病筛查及相 关因素调[J]. 中国妇幼保健, 2012, 27(3): 403-406. Gao Pan, Zhang Xiujun, Yu Yuling, et al. Screening of breast diseases and investigation on related factors among the married women in rural area of Bangbu city[J]. Maternal & Child Health Care of China, 2012, 27(3): 403-406.
[11]
许涛, 沈念春, 何造雄, 等. 乳腺增生症危险因素的病例对照研究[J]. 中国妇幼保健, 2009, 24(12): 1666-1668. Xu Tao, Shen Nianchun, He Zaoxiong, et al. A case-control study on risk factors of mammary hyperplasia[J]. Maternal & Child Health Care of China, 2009, 24(12): 1666-1668.
[12]
蔡鼎男, 林劲, 陈碧珠, 等. 体检人群中乳腺增生症患者的危险因素 调查[J]. 莆田学院学报, 2011, 18(2): 24-27. Cai Dingnan, Lin Jin, Chen Bizhu, et al. Research on risk factors of hyperplasia of mammary gland in physical examination opulation [J]. Journal of Putian University, 2011, 18(2): 24-27.
[13]
Allison K H, Eby P R, Kohr J, et al. Lehman atypical ductal hyperplasia on vacuum-assisted breast biopsy: Suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade[J]. Human Pathology, 2011, 42(1): 41-50.
[14]
哈木拉提·吾甫尔, 阿不都热依木·玉苏甫, 努尔买买提·艾买提. 维 吾尔医异常黑胆质新论[M]. 乌鲁木齐: 新疆人民出版社, 2009. Upur Hamulati, Yusup Abdiryim, Amat Nurmuhammat. New conception on the theory of Abnormal Sawda in Traditional Uighur Medicine[M]. Urumqi: Xinjiang People's Publishing House, 2009.
